Cerixen Capsules — Ceritinib 150 mg (90 Caps) Everest
Cerixen 150 mg (Ceritinib) is a potent targeted therapy and an inhibitor of anaplastic lymphoma kinase (ALK), serving as a generic equivalent to Zykadia. It works by blocking the action of the abnormal ALK protein that causes cancer cells to grow and divide. It is particularly valuable for patients who have developed resistance to prior therapies like crizotinib.
Manufacturer: Everest Pharmaceuticals (Bangladesh). Designed specifically for ALK-positive lung cancer patients.
Key Features:
- ✅ Second-Generation ALK Inhibitor: Provides a treatment option when first-line therapies fail.
- ✅ Targeted Precision: Specifically inhibits ALK phosphorylation, halting tumor proliferation.
- ✅ Optimized Regimen: The 150 mg capsule formulation allows for dosing with food, improving gastrointestinal tolerability.
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 25.03.2026
What Customers Say
No reviews yet
Your review can be the first!